The effect of weight history on glucose and lipids: The atherosclerosis risk in communities study

American Journal of Epidemiology

Volumn 161, Issue 12, 2005, Pages 1133-1143

  Truesdale, Kimberly P ^a   Stevens, June ^a,b   Cai, Jianwen ^a  

^a IL   (United States)

^b University of North Carolina   (United States)

Author keywords

Glucose; Lipoproteins, HDL cholesterol; Lipoproteins, LDL cholesterol; Obesity; Triglycerides; Weight gain; Weight loss

Indexed keywords

ANTILIPEMIC AGENT; BILE ACID SEQUESTRANT; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINAMIDE; TRIACYLGLYCEROL;

BODY CONDITION; HEALTH RISK;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; ATHEROSCLEROSIS; BODY MASS; BODY WEIGHT; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN; WEIGHT REDUCTION;

ALCOHOL DRINKING; ARTERIOSCLEROSIS; BLOOD GLUCOSE; BODY MASS INDEX; BODY WEIGHT; CAUSALITY; COMORBIDITY; CONTINENTAL POPULATION GROUPS; FEMALE; HUMANS; LIPIDS; MALE; MARYLAND; MIDDLE AGED; MINNESOTA; MISSISSIPPI; NORTH CAROLINA; OBESITY; REFERENCE VALUES; RISK FACTORS; SEX DISTRIBUTION; SMOKING; SOCIOECONOMIC FACTORS;

EID: 20544475399     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/aje/kwi151     Document Type: Article

References (43)

1. Centers for Disease Control and Prevention. The burden of chronic diseases and their risk factors: national and state perspectives 2004. Atlanta, GA: National Center for Chronic Disease Prevention and Health Promotion, 2004. (http://www.cdc.gov/nccdphp/burdenbook2004/).
2. US Department of Health and Human Services. The Surgeon General's call to action to prevent and decrease overweight and obesity. Rockville, MD: US Department of Health and Human Services, 2001. (http://www.surgeongeneral.gov/ topics/obesity/calltoaction/toc.htm).
3. US Department of Health and Human Services. The health benefits of smoking cessation: a report of the US Surgeon General. Washington, DC: US Department of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 1990. (DHHS publication no. (CDC) 90-8416).
4. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults-The Evidence Report. National Institutes of Health. Obes Res 1998; 6(suppl 2):51S-209S.
5. Blackburn G. Effect of degree of weight loss on health benefits. Obes Res 1995;3(suppl 2):211s-16s.
6. Pi-Sunyer FX. Short-term medical benefits and adverse effects of weight loss. Ann Intern Med 1993;119:722-6.
7. Goldstein DJ. Beneficial health effects of modest weight loss. Int J Obes 1992;16:397-415.
8. Chan JM, Rimm EB, Colditz GA, et al. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care 1994;17:961-9.
9. Field AE, Manson JE, Laird N, et al. Weight cycling and the risk of developing type 2 diabetes among adult women in the United States. Obes Res 2004;12:267-74.
10. Ford ES, Williamson DF, Liu S. Weight change and diabetes incidence: findings from a national cohort of US adults. Am J Epidemiol 1997;146:214-22.
11. Colditz GA, Willett WC, Rotnitzky A, et al. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med 1995;122:481-6.
12. Ishikawa-Takata K, Ohta T, Moritaki K, et al. Obesity, weight change and risks for hypertension, diabetes and hypercholesterolemia in Japanese men. Eur J Clin Nutr 2002; 56:601-7.
13. Berns MA, de Vries JH, Katan MB. Increase in body fatness as a major determinant of changes in serum total cholesterol and high density lipoprotein cholesterol in young men over a 10-year period. Am J Epidemiol 1989;130:1109-22.
14. Wing RR, Jeffery RW, Hellerstedt WL. A prospective study of effects of weight cycling on cardiovascular risk factors. Arch Intern Med 1995;155:1416-22.
15. The ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol 1989;129:687-702.
16. Siedel J, Hagele EO, Ziegenhorn J, et al. Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem 1983;29:1075-80.
17. Nagele U, Hagele E, Sauer G, et al. Reagent for the improved lipolytic efficiency. J Clin Chem Clin Biochem 1984;22: 165-74.
18. Warnick GR, Benderson J, Albers JJ. Dextran sulfate-Mg2+ precipitation procedure for quantification of high-density-lipoprotein cholesterol. Clin Chem 1982;28:1379-88.
19. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
20. Little RC, Milliken GA, Stroup WW, et al. SAS system for mixed models. Gary, NC: SAS Institute, Inc, 1996.
21. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403.
22. Long SD, O'Brien K, MacDonald KG Jr, et al. Weight loss in severely obese subjects prevents the progression of impaired glucose tolerance to type II diabetes. A longitudinal interventional study. Diabetes Care 1994;17:372-5.
23. Eriksson KF, Lindgarde F. Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmo feasibility study. Diabetologia 1991;34: 891-8.
24. Wing RR, Venditti E, Jakicic JM, et al. Lifestyle intervention in overweight individuals with a family history of diabetes. Diabetes Care 1998;21:350-9.
25. Wannamethee SG, Shaper AG. Weight change and duration of overweight and obesity in the incidence of type 2 diabetes. Diabetes Care 1999;22:1266-72.
26. Noppa H. Body weight change in relation to incidence of ischemic heart disease and change in risk factors for ischemic heart disease. Am J Epidemiol 1980;111: 693-704.
27. Higgins M, D'Agostino R, Kannel W, et al. Benefits and adverse effects of weight loss: observations from the Framingham Study. Ann Intern Med 1993;119:758-63.
28. Brownell KD, Stunkard AJ. Differential changes in plasma high-density-lipoprotein-cholesterol levels in obese men and women during weight reduction. Arch Intern Med 1981;141: 1142-6.
29. Weisweiler P. Plasma lipoproteins and lipase and lecithin:cholesterol acyltransferase activities in obese subjects before and after weight reduction. J Clin Endocrinol Metab 1987; 65:969-73.
30. Nieman DC, Haig JL, Fairchild KS, et al. Reducing-diet and exercise-training effects on serum lipids and lipoproteins in mildly obese women. Am J Clin Nutr 1990;53:640-5.
31. Weinsier RL, Johnston MH, Doleys DM, et al. Dietary management of obesity: evaluation of the time-energy displacement diet in terms of its efficacy and nutritional adequacy for long-term weight control. Br J Nutr 1982;47:367-79.
32. Zimmerman J, Kaufmann NA, Fainaru M, et al. Effects of weight loss in moderate obesity on plasma lipoprotein and apolipoprotein levels and on high density lipoprotein composition. Arteriosclerosis 1984;4:115-23.
33. Weinsier RL, James LD, Darnell BE, et al. Lipid and insulin concentrations in obese postmenopausal women: separate effects of energy restriction and weight loss. Am J Clin Nutr 1992;56:44-9.
34. Wadden TA, Anderson DA, Foster GD. Two-year changes in lipids and lipoproteins associated with the maintenance of a 5% to 10% reduction in initial weight: some findings and some questions. Obes Res 1999;7:170-8.
35. Weight cycling. National Task Force on the Prevention and Treatment of Obesity. JAMA 1994;272:1196-202.
36. French SA, Jeffery RW, Folsom AR, et al. Weight loss maintenance in young adulthood: prevalence and correlations with health behavior and disease in a population-based sample of women aged 55-69 years. Int J Obes 1996;20:303-10.
37. Meltzer AA, Everhart JE. Unintentional weight loss in the United States. Am J Epidemiol 1995;142:1039-46.
38. French SA, Jeffery RW, Folsom AR, et al. Relation of weight variability and intentionality of weight loss to disease history and health-related variables in a population-based sample of women aged 55-69 years. Am J Epidemiol 1995;142: 1306-14.
39. de Leiva A. What are the benefits of moderate weight loss? Exp Clin Endocrinol Diabetes 1998;106:10-13.
40. Klein S. Outcome success in obesity. Obes Res 2001;9 (suppl 4):354S-8S.
41. Wing RR, Hill JO. Successful weight loss maintenance. Ann Rev Nutr 2001;21:323-41.
42. Mertens IL, Van Gaal LF. Overweight, obesity, and blood pressure: the effects of modest weight reduction. Obes Res 2000;8:270-8.
43. Van Gaal LF, Wauters MA, De Leeuw IH. The beneficial effects of modest weight loss on cardiovascular risk factors. Int J Obes Relat Metab Disord 1997;21(suppl 1):S5-9.